For healthcare professionals
The Leukaemia Foundation provides a range of trusted resources and services to support people with blood cancer and the healthcare professionals who provide their care.
Our team has been working closely with treating specialists, allied health professionals and general practitioners across Australia for more than 50 years.
Need help?
Diseases we support
Our Support Care Case Managers provide support for people living blood cancers and disorders. Our accommodation services are available for people living with all cancers. Please call 1800 620 420 to discuss how we can help.
Get support
Refer your patient
We provide the following direct support services:
- Accommodation near hospitals for regional, rural and remote cancer patients
- Emotional assistance delivered by our trained support team
- Transport referrals and vouchers for patients who must travel for treatment
- Financial information about concessions, grants, rebates and other assistance options
If you’d like assistance for your patient, please complete our referral form and we’ll get back to them within two business days. If you need to talk to one of our team directly, please call 1800 620 420.
Resources
Order blood cancer resources
Our evidence-based resources provide detailed information about a range of blood cancers and disorders. These can be downloaded or hard copy booklets can be ordered for your ward or practice.
Subscribe
Subscribe to our healthcare professional newsletter
This newsletter includes the latest information about products and services available to support people with blood cancer and their healthcare teams.
Support groups
Webinars and online support groups
These online events deliver information about blood cancer support for healthcare professionals, patients and their loved ones, and provide safe places for people to share their lived experiences.
Optimal Care Pathways
Optimal Care Pathways for healthcare professionals
The blood cancer optimal care pathways and patient guides help ensure you and your patients have access to the same, nationally consistent information.
Clinical guidelines
AML clinical guidelines
These clinical guidelines provide evidence-based recommendations to help healthcare professionals deliver nationally consistent, high-quality care.
Blood Cancers A-Z
A
AA secondary amyloidosis
Acute lymphoblastic leukaemia ALL
Acute myeloid leukaemia AML
Acute myelomonocytic leukaemia AMML
Acute promyelocytic leukaemia APML
Afib mutated fibrinogen alpha chain amyloidosis
AL systemic amyloidosis
Amyloidosis
Aplastic anaemia AA
ATTR familial amyloidotic polyneuropathy
ATTR wild type senile amyloidosis
B
Biphenotypic leukaemia
Bisphosphonates myeloma
C
Chronic lymphocytic leukaemia CLL
Chronic myeloid leukaemia CML
H
Hairy cell leukaemia
Hodgkin lymphoma
I
IgA myeloma
IgG myeloma
J
Juvenile myelomonocytic leukaemia JMML
L
Langerhans Cell Histiocytosis LCH
Leukaemia
Light chain myeloma
Lymphocyte depleted HL
Lymphocyte rich HL
Lymphoma
M
MDS with biallelic TP53 inactivation MDS-biTP53
MDS with fibrosis
MDS with hypoplastic MDS-h
MDS with increased blasts MDS-IB1
MDS with increased blasts MDS-IB2
MDS with low blasts MDS-LB
MDS with low blasts and isolated 5q deletion MDS-5q
MDS with low blasts and SF3B1 mutation MDS-SF3B1
Mixed cellularity HL
Monoclonal gammopathy of unknown significance MGUS
MPN Chronic eosinophilic leukaemia CEL
MPN Chronic myelomonocytic leukaemia CMML
MPN Chronic myelomonocytic leukaemia CMML
MPN Chronic neutrophilic leukaemia CNL
MPN Essential thrombocythaemia ET
MPN Polycythaemia Rubra vera PV
MPN Primary myelofibrosis MF
MPN Systemic mastocytosis SM
Multiple myeloma
Myelodysplasia Myelodysplastic neoplasms MDS
Myeloma
Myeloid sarcoma localised leukaemia
Myeloproliferative neoplasms MPN
N
NHL Adult T-Cell leukaemic ATLL
NHL Anaplastic large cell ALCL
NHL Burkitt’s
NHL Cutaneous T-Cell
NHL Diffuse large B-cell DLBCL
NHL Double hit DHL
NHL Follicular
NHL Lymphoplasmacytic Waldenstrom’s macroglobulinaemia WM
NHL MALT
NHL Mantle cell
NHL Marginal zone
NHL Peripheral T-Cell
NHL Primary cutaneous B-cell
NHL Primary mediastinal B-cell PMBCL
NHL Small lymphocytic SLL
NHL Subcutaneous panniculitis-like T-Cell
NHL T-Lymphoblastic
NHL Waldenstroms macroglobulinaemia
Non-Hodgkin lymphoma
Nodular lymphocyte predominant HL
Nodular sclerosing HL
O
Osteosclerotic myeloma
P
Paroxysmal nocturnal haemoglobinuria
Plasmacytoma localised myeloma
POEMS syndrome
R
Richter’s syndrome leukaemia
S
Smouldering indolent myeloma
Solitary plasmacytoma myeloma
Systemic mastocytosis